• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday

    9/30/22 4:49:51 AM ET
    $ACVA
    $ADTX
    $AKUS
    $AMPS
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACVA alert in real time by email

    Gainers

    • Senti Biosciences, Inc. (NASDAQ:SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) climbed 30.3% to close at $1.55 after the company announced it was awarded a $14.8 million U.S. Army Global Force Information Management system contract.
    • Vertical Aerospace Ltd. (NASDAQ:EVTL) gained 27.2% to close at $9.64.
    • Avalon GloboCare Corp. (NASDAQ:AVCO) gained 25.8% to close at $0.7049. Avalon GloboCare received allowance for joint U.S. Patent.
    • TuanChe Limited (NASDAQ:TC) gained 25.3% to close at $3.07. TuanChe posted a H1 loss of $0.11 per share.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) surged 24.2% to close at $5.13 following the company's presentation at the AAO 2022 Annual Meeting.
    • Mill City Ventures III, Ltd. (NASDAQ:MCVT) climbed 23.6% to close at $2.62.
    • HeartBeam, Inc. (NASDAQ:BEAT) surged 21.5% to settle at $4.18 on continued strength after the company on Wednesday announced a patent grant.
    • Sientra, Inc. (NASDAQ:SIEN) gained 21% to close at $0.6096. Sientra recently received regulatory approval to market breast implants in Saudi Arabia.
    • Jupiter Wellness, Inc. (NASDAQ:JUPW) climbed 20.5% to close at $0.7334. Jupiter Wellness announced application for dual listing on upstream.
    • Akouos, Inc. (NASDAQ:AKUS) climbed 16.8% to close at $6.30. William Blair initiated coverage on Akouos with an Outperform rating and announced a price target of $12.
    • Harrow Health, Inc. (NASDAQ:HROW) rose 16.3% to close at $11.52. The FDA approved Harrow Health and Sintetica S.A's Iheezo (chloroprocaine hydrochloride ophthalmic gel) 3% for ocular surface anesthesia.
    • Stryve Foods, Inc. (NASDAQ:SNAX) gained 14.6% to close at $0.52.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) gained 13.8% to close at $1.98 after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and $12 price target.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) rose 13.7% to close at $32.40.
    • Tyra Biosciences, Inc. (NASDAQ:TYRA) surged 13.3% to close at $8.78.
    • Immunovant, Inc. (NASDAQ:IMVT) gained 12.3% to close at $5.38. Chardan Capital maintained Immunovant with a Buy and lowered the price target from $14 to $12.
    • SilverSun Technologies, Inc. (NASDAQ:SSNT) rose 11.3% to close at $2.76 after the company announced it entered into a definitive agreement and plan of merger with Rhodium Enterprises.
    • Aditxt, Inc. (NASDAQ:ADTX) shares climbed 10.5% to close at $3.38. Aditxt said it has regained compliance with Nasdaq listing requirements.
    • Motus GI Holdings, Inc. (NASDAQ:MOTS) shares rose 9% to close at $2.55 after the company was recognized as a sole source provider by the Veterans Health Administration.
    • Performance Shipping Inc. (NASDAQ:PSHG) climbed 8.8% to close at $0.2394.
    • BK Technologies Corporation (NYSE:BKTI) rose 8.8% to close at $2.34. BK Technologies received a $1 million purchase order for BKR 5000 from Virginia Department of Forestry.
    • Ero Copper Corp. (NYSE:ERO) gained 7.3% to close at $11.18.
    • Hempacco Co., Inc. (NASDAQ:HPCO) rose 7.1% to close at $2.58. Hempacco recently announced the release of Hemp Hop Smokables on www.HempHop.shop.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) gained 7% to close at $0.3734.
    • Enerpac Tool Group Corp. (NYSE:EPAC) gained 7% to close at $17.97 following upbeat Q4 results.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) gained 6.2% to close at $3.44. Mind Medicine recently priced a 7.05 million share offering of common shares and warrants at $4.25 per share plus warrants.
    • Windtree Therapeutics, Inc (NASDAQ:WINT) rose 6.2% to close at $0.34 after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European Journal of Heart Failure.
    • BioRestorative Therapies, Inc. (NASDAQ:BRTX) gained 5.3% to close at $2.98. Maxim Group initiated coverage on the stock with a Buy rating and $6 price target.


    Losers

    • Sunlight Financial Holdings Inc. (NYSE:SUNL) shares dipped 57.1% to close at $1.08 on Thursday after the company announced it is withdrawing its previously-provided full-year 2022 outlook metrics. Citigroup downgraded Sunlight Finl from Buy to Sell and lowered the price target from $4 to $2.
    • Atlis Motor Vehicles Inc (NASDAQ:AMV) shares dipped 54.8% to close at $33.95. The company recently posted a loss of $2.06 per share for the quarter ending June 30, 2022.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) fell 49.3% to close at $1.01.
    • MoneyLion Inc. (NYSE:ML) dropped 29.5% to settle at $0.8038.
    • Twin Vee Powercats Co. (NASDAQ:VEEE) fell 29% to close at $2.52 after the company priced a 2.5 million share public offering at $2.75 per share.
    • Rite Aid Corporation (NYSE:RAD) dipped 28% to settle at $5.06 after the company reported worse-than-expected Q2 EPS and lowered its FY23 adjusted EBITDA guidance. The company also said it expects continued pressure on consumer spending and supply chain challenges.
    • Isoray, Inc. (NYSE:ISR) fell 27.4% to close at $0.2199 after the company announced it entered into a definitive agreement to acquire Viewpoint Molecular Targeting.
    • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) fell 26.1% to close at $0.19 after the company on Wednesday announced it received a notice that its partner SFJ Pharmaceuticals Group elected to transfer bentracimab rights to SFJ as PhaseBio failed to remedy its Going Concern Condition.
    • SAI.TECH Global Corporation (NASDAQ:SAI) fell 26.1% to close at $2.26.
    • Pioneer Power Solutions, Inc. (NASDAQ:PPSI) dropped 25.5% to close at $3.09.
    • FaZe Holdings Inc. (NASDAQ:FAZE) dropped 24.9% to close at $9.26.
    • Altus Power, Inc. (NYSE:AMPS) fell 23.7% to close at $10.86. Altus Power priced its 7 million share secondary underwritten public offering of class A common stock at $11.50 per share.
    • PepGen Inc. (NASDAQ:PEPG) shares fell 23.5% to close at $8.36 after jumping 110% on Wednesday. PepGen reported data from PGN-EDO51's SAD study in adult healthy volunteers that suggest best-in-class exon skipping capabilities.
    • CarMax, Inc. (NYSE:KMX) fell 23.5% to $66.05 after the company reported worse-than-expected Q2 results.
    • Galecto, Inc. (NASDAQ:GLTO) dropped 22.1% to close at $1.87. Galecto announced results from a planned intermediate assessment of its ongoing MYLOX-1 Phase 2a trial of GB2064 for myelofibrosis.
    • SOBR Safe, Inc. (NASDAQ:SOBR) fell 21.9% to close at $1.93 after the company announced pricing of a $6 million private placement priced at-the-market.
    • Pintec Technology Holdings Limited (NASDAQ:PT) fell 21.3% to close at $0.3172.
    • BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) dropped 20.5% to close at $0.6599 after the company filed for an ADS offering.
    • Carvana Co. (NYSE:CVNA) fell 19.7% to close at $21.57 in sympathy with CarMax after the stock plunged following the company's weak second-quarter results.
    • REE Automotive Ltd. (NASDAQ:REE) dropped 18.7% to close at $0.6179.
    • Kaleyra, Inc. (NYSE:KLR) fell 18.6% to close at $1.05.
    • Pineapple Energy Inc. (NASDAQ:PEGY) fell 18.6% to close at $0.9036 after dipping around 23% on Wednesday. Pineapple Energy recently named Eric Ingvaldson as new Chief Financial Officer.
    • Missfresh Limited (NASDAQ:MF) fell 18.1% to close at $0.0950 after surging around 35% on Wednesday.
    • Nano Labs Ltd (NASDAQ:NA) fell 17.6% to close at $1.73.
    • Milestone Scientific Inc. (NASDAQ:MLSS) dropped 17.6% to close at $0.71.
    • Qutoutiao Inc. (NASDAQ:QTT) dropped 17.1% to close at $0.5659.
    • Nordic American Tankers Limited (NYSE:NAT) fell 16.6% to close at $2.67.
    • NantHealth, Inc. (NASDAQ:NH) fell 16.1% to close at $0.2423.
    • Arqit Quantum Inc. (NASDAQ:ARQQ) declined 16.1% to settle at $5.75.
    • NexImmune, Inc. (NASDAQ:NEXI) dropped 15.7% to close at $0.5580. NexImmune and Selexis recently signed a service agreement to develop cell lines targeting rare cancers and autoimmune diseases.
    • View, Inc. (NASDAQ:VIEW) fell 15% to settle at $1.30.
    • Hippo Holdings Inc. (NYSE:HIPO) dropped 14.8% to close at $0.7404.
    • MillerKnoll, Inc. (NASDAQ:MLKN) fell 14.7% to close at $16.96 after the company issued Q2 guidance below estimates. Craig-Hallum downgraded the stock from Buy to Hold and lowered its price target from $50 to $20.
    • ContextLogic Inc. (NASDAQ:WISH) fell 14.5% to close at $0.8121.
    • Peloton Interactive, Inc. (NASDAQ:PTON) fell 14.4% to close at $5.26 as economic concerns pressurized discretionary stocks.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) dropped 14% to close at $2.90.
    • Lufax Holding Ltd (NYSE:LU) fell 12.8% to close at $2.52.
    • Worthington Industries, Inc. (NYSE:WOR) dipped 12.4% to close at $42.99 after the company reported Q1 earnings results.
    • ACV Auctions Inc. (NASDAQ:ACVA) dipped 12% to close at $7.82.
    • Sonic Automotive, Inc. (NYSE:SAH) fell 11.7% to close at $42.71.
    • Orchid Island Capital, Inc. (NYSE:ORC) dropped 11.5% to close at $8.22.
    • Sunrun Inc. (NASDAQ:RUN) dropped 11.4% to close at $27.52. Shares of several companies in the broader industrials sector traded lower as stocks pull back after gaining on Wednesday.
    • AutoNation, Inc. (NYSE:AN) declined 10.4% to close at $100.77. AutoNation 10% owner Edward S. Lampert sold a total of 290,735 shares at an average price of $108.39.
    • Chimera Investment Corporation (NYSE:CIM) fell 10.2% to close at $5.26.
    • 5E Advanced Materials Inc. (NASDAQ:FEAM) fell 10.1% to close at $14.03 after the company reported FY22 EPS results were lower year over year.
    • NIO Inc. (NYSE:NIO) dropped 10.1% to close at $15.58. Shares of Chinese companies traded lower as global equities fall amid US economic concerns and currency uncertainty.
    • Terran Orbital Corporation (NASDAQ:LLAP) fell 9.3% to close at $2.15.
    • XPeng Inc. (NYSE:XPEV) fell 9.2% to close at $12.11. Shares of Chinese companies traded lower as global equities fell amid US economic concerns and currency uncertainty.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 7.7% to close at $0.5956 after gaining around 8% on Wednesday.
    • Toast, Inc. (NYSE:TOST) fell 7.3% to close at $17.47 after gaining 5% on Wednesday.

     

    Get the next $ACVA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACVA
    $ADTX
    $AKUS
    $AMPS

    CompanyDatePrice TargetRatingAnalyst
    Galecto Inc.
    $GLTO
    2/17/2026$45.00Buy
    UBS
    Tyra Biosciences Inc.
    $TYRA
    2/10/2026Outperform
    William Blair
    MillerKnoll Inc.
    $MLKN
    2/10/2026Outperform
    William Blair
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Ero Copper Corp.
    $ERO
    2/9/2026Buy → Neutral
    BofA Securities
    Peloton Interactive Inc.
    $PTON
    2/6/2026$8.00 → $6.00Market Perform
    Telsey Advisory Group
    Toast Inc.
    $TOST
    2/2/2026$42.00 → $36.00Neutral
    DA Davidson
    Tyra Biosciences Inc.
    $TYRA
    1/28/2026$59.00Overweight
    Barclays
    More analyst ratings

    $ACVA
    $ADTX
    $AKUS
    $AMPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Zeltser Guy bought $4,808 worth of shares (665 units at $7.23) and covered exercise/tax liability with 4,483 shares, decreasing direct ownership by 6% to 65,042 units (SEC Form 4)

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    2/18/26 7:02:59 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    Large owner Rusnak Paul P. bought $5,994,472 worth of SAH (100,000 units at $59.94), increasing direct ownership by 2% to 5,100,000 units (SEC Form 4)

    4 - SONIC AUTOMOTIVE INC (0001043509) (Issuer)

    2/18/26 6:46:07 PM ET
    $SAH
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Chief Executive Officer Chamoun George bought $123,312 worth of shares (16,892 units at $7.30), increasing direct ownership by 0.58% to 2,928,705 units (SEC Form 4)

    4 - ACV Auctions Inc. (0001637873) (Issuer)

    2/10/26 4:48:21 PM ET
    $ACVA
    Real Estate

    $ACVA
    $ADTX
    $AKUS
    $AMPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS initiated coverage on Galecto with a new price target

    UBS initiated coverage of Galecto with a rating of Buy and set a new price target of $45.00

    2/17/26 8:59:23 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Tyra Biosciences

    William Blair initiated coverage of Tyra Biosciences with a rating of Outperform

    2/10/26 8:03:00 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on MillerKnoll

    William Blair initiated coverage of MillerKnoll with a rating of Outperform

    2/10/26 8:01:31 AM ET
    $MLKN
    Office Equipment/Supplies/Services
    Consumer Discretionary

    $ACVA
    $ADTX
    $AKUS
    $AMPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ocular Therapeutix™ to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations

    Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to host an investor webcast on Monday, March 2, 2026, at 7:30 AM ET to discuss the Macula Society presentations BEDFORD, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the Company will present detailed results from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI™ (also known as OTX-TKI), for the treatment of wet age-related macular degeneration (wet AMD), at the 49th Macula Soc

    2/23/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

    SOUTH SAN FRANCISCO, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it participated in a Cell & Gene Live virtual event focused on emerging and enabling technologies designed to advance the development of innovative cell therapies. The Cell & Gene Live webinar, held on February 19, 2026, convened industry leaders and innovators to discuss approaches aimed at improving the design, development and translation of cell therapies. The Company shared perspectives on how its Gene Circuit-based a

    2/20/26 8:50:00 AM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Tyra Biosciences to Participate in Upcoming Investor Conferences

    CARLSBAD, Calif., Feb. 19, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced participation at the following investor conferences:36th Annual Oppenheimer Life Sciences Healthcare ConferenceFormat: Virtual fireside chat and one-on-one investor meetingsPresentation Date/Time: Thursday, February 26, 2026 at 12:00pm ETLocation: Virtual46th Annual TD Cowen Healthcare ConferenceFormat: Hybrid presentation & fireside chat and one-on-one investor meetingsPresentation Date/Time: Wednesday, March 4t

    2/19/26 4:05:00 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACVA
    $ADTX
    $AKUS
    $AMPS
    SEC Filings

    View All

    SEC Form 424B4 filed by Twin Vee PowerCats Co.

    424B4 - Twin Vee PowerCats, Co. (0001855509) (Filer)

    2/23/26 6:04:07 AM ET
    $VEEE
    Marine Transportation
    Industrials

    SEC Form 10-K filed by Orchid Island Capital Inc.

    10-K - Orchid Island Capital, Inc. (0001518621) (Filer)

    2/20/26 3:26:06 PM ET
    $ORC
    Real Estate Investment Trusts
    Real Estate

    SEC Form SCHEDULE 13G filed by Tyra Biosciences Inc.

    SCHEDULE 13G - Tyra Biosciences, Inc. (0001863127) (Subject)

    2/20/26 8:14:27 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACVA
    $ADTX
    $AKUS
    $AMPS
    Leadership Updates

    Live Leadership Updates

    View All

    CarMax Names Keith Barr as Chief Executive Officer

    CarMax, Inc. (NYSE:KMX) ("CarMax" or the "Company") today announced that Keith Barr has been appointed President and Chief Executive Officer, and a member of the Board of Directors ("the Board"), effective March 16, 2026. David McCreight, current Interim President and CEO of CarMax, will transition to his prior duties as an independent Director of the Board. Tom Folliard will remain in his role as Interim Executive Chair of the Board until the Company's Annual Meeting in June 2026, after which he is expected to resume his prior duties as non-executive Chair of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026021283385

    2/12/26 6:50:00 AM ET
    $IHG
    $KMX
    Hotels/Resorts
    Consumer Discretionary
    Retail-Auto Dealers and Gas Stations

    PALMETTO APPOINTS LIZ CODDINGTON AS CHIEF FINANCIAL OFFICER

    Peloton CFO brings deep experience scaling consumer and technology-driven businesses to expand access to affordable, reliable energy CHARLOTTE, N.C., Feb. 5, 2026 /PRNewswire/ -- Palmetto, America's leading consumer energy platform, today announced the appointment of Liz Coddington as Chief Financial Officer, effective March 30th, 2026. Coddington will join Palmetto at the close of her four-year tenure as Chief Financial Officer of Peloton Interactive, Inc. (NASDAQ:PTON), where she is currently leading the company's global finance organization during a pivotal period of tran

    2/5/26 8:47:00 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Vertical Aerospace Selects Evolito as Electric Propulsion Unit Partner for Valo

    Evolito to supply electric propulsion units for Valo, Vertical's commercial aircraft Companies to jointly certify the electric engines with UK CAA and EASA Evolito joins Honeywell, Syensqo and Aciturri as key suppliers, strengthening Valo's path to commercialization Vertical Aerospace ("Vertical" or "Company") (NYSE:EVTL), a global aerospace and technology company that is pioneering electric aviation, today announced a new long-term partnership with Evolito, a leader in high-performance electric propulsion systems, to supply electric propulsion units ("EPUs") - electric engines - that will power Valo, Vertical's commercial eVTOL aircraft. This press release features multimedia. V

    2/5/26 4:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    $ACVA
    $ADTX
    $AKUS
    $AMPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Stern Peter C converted options into 59,714 shares and sold $130,214 worth of shares (31,461 units at $4.14), increasing direct ownership by 9% to 344,812 units (SEC Form 4)

    4 - PELOTON INTERACTIVE, INC. (0001639825) (Issuer)

    2/18/26 7:29:20 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Chief Commercial Officer Sanders Dion C. converted options into 235,086 shares and sold $365,040 worth of shares (88,242 units at $4.14) (SEC Form 4)

    4 - PELOTON INTERACTIVE, INC. (0001639825) (Issuer)

    2/18/26 7:28:37 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Chief Content Officer Cotter Jennifer Cunningham sold $519,966 worth of shares (125,432 units at $4.15) and converted options into 279,929 shares, increasing direct ownership by 154% to 254,766 units (SEC Form 4)

    4 - PELOTON INTERACTIVE, INC. (0001639825) (Issuer)

    2/18/26 7:27:29 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    $ACVA
    $ADTX
    $AKUS
    $AMPS
    Financials

    Live finance-specific insights

    View All

    Ocular Therapeutix™ to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations

    Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to host an investor webcast on Monday, March 2, 2026, at 7:30 AM ET to discuss the Macula Society presentations BEDFORD, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the Company will present detailed results from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI™ (also known as OTX-TKI), for the treatment of wet age-related macular degeneration (wet AMD), at the 49th Macula Soc

    2/23/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

    SOUTH SAN FRANCISCO, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it participated in a Cell & Gene Live virtual event focused on emerging and enabling technologies designed to advance the development of innovative cell therapies. The Cell & Gene Live webinar, held on February 19, 2026, convened industry leaders and innovators to discuss approaches aimed at improving the design, development and translation of cell therapies. The Company shared perspectives on how its Gene Circuit-based a

    2/20/26 8:50:00 AM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Carvana Announces Record Fourth Quarter and Full Year 2025 Results

    Record Full Year Retail Units Sold of 596,641, up 43% YoY Record Full Year Revenue of $20.3 billion, up 49% YoY Record Full Year Net Income of $1.9 billion1, up more than $1 billion YoY Record Full Year Adjusted EBITDA of $2.2 billion, up more than $850 million YoY Expects Significant Growth in Retail Units Sold and Adjusted EBITDA2 in FY 2026 and Sequential Increase in Retail Units Sold and Adjusted EBITDA2 in Q1 Carvana (NYSE:CVNA), a leading e-commerce platform for buying and selling cars, today announced financial results for the full year and quarter ended December 31, 2025. Carvana's complete fourth quarter and fiscal year 2025 financial results and management commentary are

    2/18/26 4:05:00 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $ACVA
    $ADTX
    $AKUS
    $AMPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology